QOL Medical Selects Optum Frontier Therapies as New Pharmacy Partner for Sucraid® to support CSID patients nationwide being treated with Sucraid® (sacrosidase) Oral Solution
Aetna recently announced an initiative to launch a designated network to cover new gene therapies for rare diseases. This follows an initiative by CVS Health in 2019 to provide self-insured employers with a stop-loss program with Aetna health plans and cover gene therapies
Optum® Frontier Therapies, a specialty pharmacy dedicated to people with rare disease, was founded to optimize every aspect of advanced therapeutics, from the point of prescribing to treatment and beyond
Optum Frontier Therapies Centers of Excellence (COEs) consist of dedicated teams focused on cell and gene therapy, rare disease drugs and digital therapeutics